Edesa Biotech Inc (NQ: EDSA )
4.750
+0.070
(+1.49%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Jul 19, 2024
Add to My Watchlist
All News about Edesa Biotech Inc
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal 1st Quarter 2024 Results
February 09, 2024
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Fiscal Year 2023 Results
December 15, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/12/13/image23.jpeg?width=1200&height=800&fit=crop)
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 13, 2023
Via Benzinga
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/22/urban_outfitters_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
November 20, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech to Present at Dermatology Drug Development Summit
October 26, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/13/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/13/stock_whisper_index_logo_6_copy.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/13/image45.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/12/edsa.png?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/10/12/image14.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Announces One-for-Seven Reverse Share Split
October 10, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/09/28/image41.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 28, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.